TECH · Health Care

Bio-Techne

Public Kalshi markets

01Inflation

CPI year-over-year for May 2026

Bio-Techne is included because inflation can affect Life Sciences Tools & Services costs, pricing, and demand.

50%0¢ / 100¢Quote as of 2026.06.14 09:25 UTCWide quote2026.06.10

02Rates

Will the 30-year U.S. Treasury par yield for Q2 2026 be above 4.00%?

Bio-Techne is included because long-rate outcomes shape financing costs, valuation backdrop, and capital allocation.

50%0¢ / 100¢Quote as of 2026.06.14 09:26 UTCWide quote2026.06.30

03Public health event

Will there be a pandemic in 2026?

Bio-Techne is included because public-health disruptions can affect Life Sciences Tools & Services demand, staffing, and operating continuity.

7.5%7¢ / 8¢Quote as of 2026.06.14 09:25 UTC2027.01.01

04Demand cycle

Will there be a U.S. recession in 2026?

Bio-Techne is included because procedure volumes, payer budgets, and funding conditions can shift with the macro backdrop.

14.5%14¢ / 15¢Quote as of 2026.06.14 09:25 UTC2027.01.31

05Demand cycle

will above 70,000 jobs be added in July 2026?

Bio-Techne is included because procedure volumes, payer budgets, and funding conditions can shift with the macro backdrop.

72%67¢ / 77¢Quote as of 2026.06.14 09:25 UTC2026.08.07

Exposure context

Bio-Techne's five markets cover demand cycle, rates backdrop, and event shocks. The traditional-market references below are context for how investors usually express those exposures; they are not claims about company hedging activity.

Traditional-market context

single-name equity optionssector ETF overlaysrevenue sensitivity analysis

Company-level context only, not a claim about trading activity.